The mtrB gene from Bacillus pumilus encodes a 76-amino-acid polypeptide with 77% identity to the trp RNA-binding attenuation protein (TRAP) from Bacillus subtilis. B. pumilus TRAP binds trp leader RNA from either B. subtilis or B. pumilus in a tryptophan-dependent manner. Altering threonine 52 to alanine eliminated RNA-binding activity of B. pumilus TRAP.
similarly, from overexpressing Escherichia coli SG62052/pGP1-2/pTZ18BpmtrB, except that the immunoaffinity column contained antibodies prepared against B. pumilus TRAP.
Gel mobility shift assays. Uniformly 32 P-labelled trp leader RNA transcripts were prepared as described previously (15) by using T7 RNA polymerase to transcribe pTZ18dR4 or pTZ19Bptrpl cut with HindIII or EcoRI, respectively. Labelled RNAs terminated at the attenuator were purified from denaturing polyacrylamide gels (14) . The B. subtilis transcript contained nucleotides 2 to 138 (17) , and the B. pumilus RNA contained nucleotides 1 to 153 (12) .
Gel mobility shift assays were performed as described previously (15) using 150,000 dpm of gel-purified 32 P-labelled RNA (1 ng Ϸ 0.022 pmol). B. subtilis TRAP concentrations were determined with the A 280 by using an extinction coefficient of 1,250 M
Ϫ1
, which was determined by amino acid analysis. B. pumilus TRAP concentrations were determined by Bio-Rad protein assay using B. subtilis TRAP standards.
Nucleotide sequence accession number. The sequence of the B. pumilus mtrB gene has been deposited in GenBank (accession no. L37879).
Characteristics of the B. pumilus mtrB gene. The nucleotide sequence of the B. pumilus mtr fragment contains one partial open reading frame with homology to the final 46 amino acids of MtrA (GTP cyclohydrolase I [4] ) from B. subtilis (8) and a second open reading frame highly homologous to TRAP from B. subtilis (4, 6, 8, 15) . The two open reading frames are separated by 24 bp, which contain a putative ribosome binding site for mtrB.
The deduced amino acid sequences of the B. pumilus and B. subtilis TRAP proteins are highly homologous, with 58 of the 76 residues being identical. Homology is strongest in the middle portion of the proteins, where residues 32 to 59 are identical. The amino-terminal region shows the least homology, particularly residues 2 to 6. In the recently completed threedimensional X-ray crystal structure of tryptophan-activated B. subtilis TRAP (3), the first 7 residues are not ordered in the crystal. Moreover, preliminary data from a mutant in which residues 2 to 6 were deleted suggest that these amino acids are not essential for TRAP function (6a).
B. pumilus TRAP binds to trp leader RNA from B. pumilus and B. subtilis. B. subtilis TRAP has been shown to specifically bind trp leader RNA in a tryptophan-dependent manner (15) and to cause transcription termination at the trp attenuator in vitro (6) . We found that B. pumilus TRAP also binds to trp leader RNA from either B. pumilus or B. subtilis in vitro ( (Fig. 1B) . In this case, a small amount of tryptophan-independent binding was seen (Fig. 1B , compare lanes 10 and 10*). B. pumilus TRAP did not bind to several nonspecific RNAs tested with this assay (data not shown). These results indicate that B. pumilus TRAP binds to both trp leader RNAs; however, the complexes formed may be slightly different.
As we have shown previously (15), B. subtilis TRAP binds to trp leader RNA from B. subtilis and forms a single complex seen as one shifted band, labelled C in Fig. 1D . B. subtilis TRAP also binds B. pumilus trp leader RNA, and as was seen when this RNA binds to B. pumilus TRAP, several shifted bands are observed ( (Fig. 2) . Examination of the proposed binding sites in either leader shows several subtle differences, including an unusual AAG in the second repeat of B. pumilus and several differences in the spacing between repeats. The positions of the repeats are also slightly different with relation to the antiterminator stem-loop. It is not clear what difference between these RNAs is responsible for the differences seen in the mobility shift gels when complexes are formed with either TRAP.
T52A mutant B. pumilus TRAP does not bind trp leader RNA. We discovered one clone of B. pumilus mtrB in which nucleotide 319 was changed from an A to a G, resulting in threonine 52 changing to alanine (T52A). Purified T52A TRAP did not bind trp leader RNA in a gel mobility shift assay at any amount of protein tested up to 1,000 ng (data not shown). We then compared the tryptophan dependency of B. pumilus TRAP binding to trp leader RNA for both the wildtype and mutant proteins. The wild-type protein was activated by between 1 and 10 M L-tryptophan (Fig. 3A) . In contrast, T52A was not activated at any concentration of tryptophan up to 1,200 M (Fig. 3B) . Most significantly, while the wild-type TRAP bound L-tryptophan in an equilibrium dialysis assay, T52A TRAP did not (data not shown). These results indicate that changing threonine 52 to alanine eliminates the ability of this protein to be activated by L-tryptophan to bind trp leader RNA.
Changing threonine 52 to alanine could prevent proper folding of the protein. We therefore compared the sizes of the purified B. pumilus wild-type and T52A mutant TRAP proteins with that of B. subtilis TRAP, which has recently been shown to be an 11-mer of identical subunits (2, 3, 5) . All three proteins ran similarly on a Phenomenex SEC-2000 size exclusion column (data not shown), indicating that they all have similar sizes. These results indicate that the T52A mutant polypeptide folds well enough to assemble into an 11-mer resembling the B. subtilis protein. This conclusion supports the interpretation that the loss of tryptophan binding and RNA binding of the T52A mutant reflects a specific alteration in the tryptophan binding site of this protein and does not simply result from a drastic effect on folding of the protein.
We also examined in vivo regulation of the trp operon by both wild-type and T52A B. pumilus TRAP by expressing them in B. subtilis and testing the effect of Ftrp on the resulting strains. Growth of mtrB ϩ strains is inhibited by Ftrp, whereas mtrB mutant strains continue to express the trp operon and grow (9) . B. subtilis BG4233 contains a deletion of mtrB and is resistant to Ftrp. Expressing B. pumilus mtrB from the spac promoter (20) rendered this strain sensitive to Ftrp, indicating that B. pumilus TRAP is capable of regulating the B. subtilis trp operon in vivo. In contrast, BG4233 remains resistant to Ftrp when the T52A mutant mtrB is expressed, confirming that T52A TRAP does not function to regulate the trp operon.
In the X-ray crystal structure of tryptophan-activated B. subtilis TRAP, the side chain hydroxyl of the homologous threonine 52 makes a hydrogen bond with one of the carboxylic acid oxygens of tryptophan (3). Threonine 52 is also involved in forming a hydrophobic pocket that surrounds the indole ring of the bound tryptophan. Changing this residue to alanine is predicted to disrupt both of these interactions with tryptophan. We therefore suspect that the loss of RNA binding seen with the B. pumilus T52A protein is due to the inability of this protein to bind and be activated by L-tryptophan, indicating that threonine 52 is part of the tryptophan binding domain of this protein.
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